Literature DB >> 14579887

Studies of radon and lung cancer in North America and China.

J H Lubin1.   

Abstract

Studies of radon-exposed underground miners indicate that residential radon is the second leading cause of lung cancer. Seven case-control studies of residential radon have been conducted in North America and two in China, and represent all studies in these areas which included 200 or more lung cancer cases and used long-term radon detectors. North American studies enrolled 4081 cases and 5281 controls, and Chinese studies enrolled 1076 cases and 2015 controls. Based on analyses of pooled data, odds ratios (ORs) and 95% confidence limits at 100 Bq m(-3) were 1.106 (1.00,1.28) for the North American studies and 1.139 (1.01,1.37) for the Chinese studies. Tests of homogeneity of ORs within populations were not significant. Among subjects with complete dosimetry for the 5-30 y exposure period prior to interview, ORs at 100 Bq m(-3) were 1.205 (1.03,1.50) for the North American studies and 1.279 (1.07,0.75) for the Chinese studies. Results are consistent with extrapolations from miners and indicate an excess lung cancer risk from residential radon.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579887     DOI: 10.1093/oxfordjournals.rpd.a006194

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  10 in total

1.  Radon-induced lung cancer in French and Czech miner cohorts described with a two-mutation cancer model.

Authors:  Marco J P Brugmans; Sietse M Rispens; Harmen Bijwaard; Dominique Laurier; Agnes Rogel; Ladislav Tomásek; Margot Tirmarche
Journal:  Radiat Environ Biophys       Date:  2004-08-17       Impact factor: 1.925

2.  Simultaneous measurements of radon and thoron, and their progeny levels in dwellings on anticlinal structures of Assam, India.

Authors:  Debajyoti Barooah; Simi Barman; Sarat Phukan
Journal:  Environ Monit Assess       Date:  2014-01-28       Impact factor: 2.513

3.  Residential radon appears to prevent lung cancer.

Authors:  Bobby R Scott
Journal:  Dose Response       Date:  2011-10-14       Impact factor: 2.658

4.  What proportion of lung cancer in never-smokers can be attributed to known risk factors?

Authors:  Julia Sisti; Paolo Boffetta
Journal:  Int J Cancer       Date:  2012-03-27       Impact factor: 7.396

5.  Radon, smoking, and lung cancer: the need to refocus radon control policy.

Authors:  Paula M Lantz; David Mendez; Martin A Philbert
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

Review 6.  Human exposure to high natural background radiation: what can it teach us about radiation risks?

Authors:  Jolyon H Hendry; Steven L Simon; Andrzej Wojcik; Mehdi Sohrabi; Werner Burkart; Elisabeth Cardis; Dominique Laurier; Margot Tirmarche; Isamu Hayata
Journal:  J Radiol Prot       Date:  2009-05-19       Impact factor: 1.394

7.  Epidermal growth factor receptor derived peptide vaccination to prevent lung adenocarcinoma formation: An in vivo study in a murine model of EGFR mutant lung cancer.

Authors:  Johnathan D Ebben; Ronald A Lubet; Ekram Gad; Mary L Disis; Ming You
Journal:  Mol Carcinog       Date:  2015-09-07       Impact factor: 4.784

8.  Lung cancer attributable to indoor radon exposure in france: impact of the risk models and uncertainty analysis.

Authors:  Olivier Catelinois; Agnès Rogel; Dominique Laurier; Solenne Billon; Denis Hemon; Pierre Verger; Margot Tirmarche
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

9.  Lung cancer risk in never-smokers: An overview of environmental and genetic factors.

Authors:  Elvin S Cheng; Marianne Weber; Julia Steinberg; Xue Qin Yu
Journal:  Chin J Cancer Res       Date:  2021-10-31       Impact factor: 4.026

10.  Lung cancer risk from occupational and environmental radon and role of smoking in two Czech nested case-control studies.

Authors:  Ladislav Tomasek
Journal:  Int J Environ Res Public Health       Date:  2013-03-07       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.